Evidence map›Paper›PMID 31640696›Full record

ArticleBMC veterinary research2019

Paving the way for more precise diagnosis of EcPV2-associated equine penile lesions.

Anna Sophie Ramsauer, Garrett Louis Wachoski-Dark, Cornel Fraefel, Kurt Tobler, Sabine Brandt, Cameron Greig Knight, Claude Favrot, Paula Grest

Open access · goldAbstract read
In one paragraph

Article in BMC veterinary research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Viruses · 2022
    Article
  8. Article
  9. Article
  10. PD-L1/PD-1 and CTLA-4 Expression in Equine Penile Squamous Cell Carcinomas.Animals : an open access journal from MDPI · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Anna Sophie RamsauerInstitute of Virology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland. sramsauer@vetclinics.uzh.ch.ORCID http://orcid.org/0000-0003-4741-3972
Garrett Louis Wachoski-DarkDepartment of Veterinary Clinical and Diagnostic Sciences, Faculty of Veterinary Medicine, University of Calgary, Calgary, Canada.
Cornel FraefelInstitute of Virology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Kurt ToblerInstitute of Virology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Sabine BrandtResearch Group Oncology, Equine Clinic, University of Veterinary Medicine Vienna, Vienna, Austria.
Cameron Greig KnightDepartment of Veterinary Clinical and Diagnostic Sciences, Faculty of Veterinary Medicine, University of Calgary, Calgary, Canada.
Claude FavrotDermatology Department, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Paula GrestInstitute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
University of Zurich · CHUniversity of Calgary · CAUniversity of Veterinary Medicine Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is growing evidence that equine papillomavirus type 2 (EcPV2) infection is causally associated with the development of equine genital squamous cell carcinomas (SCCs). Early stages of disease present clinically as plaques or wart-like lesions which can gradually progress to tumoural lesions. Histologically these lesions are inconsistently described as benign hyperplasia, papilloma, penile intraepithelial neoplasia (PIN), carcinoma in situ (CIS) or SCC. Guidelines for histological classification of early SCC precursor lesions are not precisely defined, leading to potential misdiagnosis. The aim of this study was to identify histologic criteria and diagnostic markers allowing for a more accurate diagnosis of EcPV2-associated equine penile lesions.

resultsA total of 61 archived equine penile lesions were histologically re-assessed and classified as benign hyperplasia, papilloma, CIS or SCC. From these, 19 representative lesions and adjacent normal skin were comparatively analysed for the presence of EcPV2 DNA and transcripts using PCR and RNA in situ hybridisation (RISH). All lesional samples were positive by EcPV2 PCR and RISH, while adjacent normal skin was negative. RISH analysis yielded signal distribution patterns that allowed distinction of early (hyperplasia, papilloma) from late stage lesions (CIS, SCC). Subsequently, the 19 lesions were further assessed for expression of p53, Ki67, MCM7 and MMP1 by immunohistochemistry (IHC). All four proteins were expressed in both normal and lesional tissue. However, p53 expression was up-regulated in basal keratinocyte layers of papillomas, CIS and SCCs, as well as in upper keratinocyte layers of CIS and SCCs. MCM7 expression was only up-regulated in upper proliferating keratinocyte layers of papillomas, CIS and SCCs.

conclusionThis study proposes combining a refined histological protocol for analysis of equine penile lesions with PCR- and/or RISH based EcPV2-screening and p53/MCM7 IHC to more accurately determine the type of lesion. This may help to guide the choice of optimum treatment strategy, especially at early stages of disease.

Indexed as

AnimalsDNA, ViralHorse DiseasesHorsesIn Situ HybridizationMalePapillomaviridaePapillomavirus InfectionsPenile NeoplasmsPenisPrecancerous ConditionsDNA, ViralBenign hyperplasiaCarcinoma in situ (CIS)Equine papillomavirus type 2 (EcPV2)ImmunohistochemistryPapillomaRNA-scopeSquamous cell carcinoma (SCC)

Identifiers

PMID31640696
PMCPMC6805557
OpenAlexW2982247074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.